Cargando…
Advancing the management of double hit lymphoma
Autor principal: | Landsburg, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667951/ https://www.ncbi.nlm.nih.gov/pubmed/29108217 http://dx.doi.org/10.18632/oncotarget.20794 |
Ejemplares similares
-
Rational targeted therapeutics for double-hit lymphoma
por: Azizian, Nancy G, et al.
Publicado: (2019) -
BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma
por: Esteve-Arenys, Anna, et al.
Publicado: (2018) -
Drug therapy for double-hit lymphoma
por: Phuoc, Vania, et al.
Publicado: (2019) -
De Novo CD5-Positive Primary Gastric Diffuse Large B-Cell Lymphoma Coexpressing MYC and BCL6: Towards a Proper Subset of Double-Hit, Triple-Hit and, Maybe, Quadruple-Hit B-Cell Lymphomas?
por: Roncati, Luca
Publicado: (2018) -
Double hit mouse model of Parkinson's disease
por: Schirinzi, Tommaso, et al.
Publicado: (2016)